These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 12554071

  • 1. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release.
    Streubel A, Siepmann J, Bodmeier R.
    Eur J Pharm Sci; 2003 Jan; 18(1):37-45. PubMed ID: 12554071
    [Abstract] [Full Text] [Related]

  • 2. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
    Loh ZC, Elkordy AA.
    Curr Drug Deliv; 2015 Jan; 12(4):425-43. PubMed ID: 25924732
    [Abstract] [Full Text] [Related]

  • 3. Preparation and evaluation of gastroretentive floating tablets of acyclovir.
    Garg R, Gupta GD.
    Curr Drug Deliv; 2009 Oct; 6(5):437-43. PubMed ID: 19751200
    [Abstract] [Full Text] [Related]

  • 4. Preparation and evaluation of gastroretentive floating tablets of Silymarin.
    Garg R, Gupta GD.
    Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):545-9. PubMed ID: 19483331
    [Abstract] [Full Text] [Related]

  • 5. Development of Valsartan Floating Matrix Tablets Using Low Density Polypropylene Foam Powder: In vitro and In vivo Evaluation.
    Rahamathulla M, Saisivam S, Gangadharappa HV.
    AAPS PharmSciTech; 2019 Jan 02; 20(1):35. PubMed ID: 30604045
    [Abstract] [Full Text] [Related]

  • 6. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H, Garrait G, Tamani F, Beyssac E, Hoffart V.
    Pharm Res; 2017 Feb 02; 34(2):365-377. PubMed ID: 28004316
    [Abstract] [Full Text] [Related]

  • 7. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C, Yüksel-Tilkan G, Türkmen B, Ozdemir N.
    Acta Pharm; 2011 Sep 01; 61(3):303-12. PubMed ID: 21945909
    [Abstract] [Full Text] [Related]

  • 8. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY, Yang YP, Chang JB, Guo MT.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct 18; 44(5):742-8. PubMed ID: 23073585
    [Abstract] [Full Text] [Related]

  • 9. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A, Abrahmsén-Alami S, Wittgren B, Larsson A.
    Eur J Pharm Biopharm; 2011 Aug 18; 78(3):470-9. PubMed ID: 21316446
    [Abstract] [Full Text] [Related]

  • 10. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y, Khanvilkar KH, Moore AD, Hilliard-Lott M.
    Drug Dev Ind Pharm; 2003 Jan 18; 29(1):79-88. PubMed ID: 12602495
    [Abstract] [Full Text] [Related]

  • 11. Release kinetics of highly porous floating tablets containing cilostazol.
    Hwang KM, Cho CH, Tung NT, Kim JY, Rhee YS, Park ES.
    Eur J Pharm Biopharm; 2017 Jun 18; 115():39-51. PubMed ID: 28219750
    [Abstract] [Full Text] [Related]

  • 12. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R, Dashevsky A, Bodmeier R.
    Int J Pharm; 2017 Jan 10; 516(1-2):3-8. PubMed ID: 27818241
    [Abstract] [Full Text] [Related]

  • 13. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY, Lin KH, Li MJ.
    J Pharm Sci; 2002 Sep 10; 91(9):2040-6. PubMed ID: 12210050
    [Abstract] [Full Text] [Related]

  • 14. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S, Mazumder B, Chattopadhyay S, Das MK, Sinha S, Ganguly S, De K, Mishra M.
    Int J Biol Macromol; 2014 Apr 10; 65():346-56. PubMed ID: 24472506
    [Abstract] [Full Text] [Related]

  • 15. Release mechanisms behind polysaccharides-based famotidine controlled release matrix tablets.
    Elmowafy EM, Awad GA, Mansour S, El-Shamy Ael-H.
    AAPS PharmSciTech; 2008 Apr 10; 9(4):1230-9. PubMed ID: 19089643
    [Abstract] [Full Text] [Related]

  • 16. Gastroretentive Matrix Tablets of Boswellia Oleogum Resin: Preparation, Optimization, In Vitro Evaluation, and Cytoprotective Effect on Indomethacin-Induced Gastric Ulcer in Rabbits.
    Yusif RM, Abu Hashim II, Mohamed EA, Badria FA.
    AAPS PharmSciTech; 2016 Apr 10; 17(2):328-38. PubMed ID: 26092303
    [Abstract] [Full Text] [Related]

  • 17. Development of bilayer floating tablet of amoxicillin and Aloe vera gel powder for treatment of gastric ulcers.
    Ranade AN, Wankhede SS, Ranpise NS, Mundada MS.
    AAPS PharmSciTech; 2012 Dec 10; 13(4):1518-23. PubMed ID: 23135966
    [Abstract] [Full Text] [Related]

  • 18. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC, Sumitra G M.
    J Control Release; 2002 Feb 19; 79(1-3):157-64. PubMed ID: 11853927
    [Abstract] [Full Text] [Related]

  • 19. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D, Ojsteršek T, Vrečer F.
    Drug Dev Ind Pharm; 2018 Sep 19; 44(9):1543-1550. PubMed ID: 29848075
    [Abstract] [Full Text] [Related]

  • 20. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS, Bhatia MS.
    PDA J Pharm Sci Technol; 2008 Sep 19; 62(5):344-52. PubMed ID: 19055230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.